SenzaGen Investor Relations Material
Latest events
Q1 2025
SenzaGen
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from SenzaGen
Access all reports
SenzaGen is a Sweden-based biotechnology company specializing in non-animal test methods for assessing chemical safety. The company develops and markets in vitro assays for detecting skin sensitization and other toxicological endpoints. Its technology is used in industries including cosmetics, chemicals, and pharmaceuticals. SenzaGen is headquartered in Lund, Sweden, and its shares are listed on the NASDAQ First North Growth Market.
Latest articles
)
Pershing Square Capital Management: Conviction, Reinvention, and Contrarian Investing
Pershing Square Capital Management has grown into a top-tier hedge fund through reinvention, conviction, and focus on long-term value creation.
2 Jul 2025
)
Eli Lilly: The Pharma Giant Behind Mounjaro and Zepbound
Eli Lilly's journey from insulin pioneer to global pharma giant, leading innovation in diabetes, obesity, and the future of metabolic health.
30 Jun 2025
)
500 Years of Craft, One Family Legacy: Beretta Holding's Global Expansion
How Beretta Holding managed to transform from a 16th-century gun barrel producer into a global industrial group while preserving 500 years of legacy.
27 Jun 2025
Ticker symbol
SENZA
Country
🇸🇪 Sweden